FDA Inspection 1046483 — Hangzhou Karic Commodities Co., Ltd.
The FDA completed an inspection of Hangzhou Karic Commodities Co., Ltd. on March 29, 2018 in Hangzhou. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- March 29, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hangzhou (China)